R&D activities

Immundnz is an R&D performing SME

We have recently completed a European funded R&D project. The project was aimed at developing an in vitro human cell based platform that will enable the preclinical study of drug induced immunogenicity and the risk of immune mediated pathology. COMPIT, Comprehensive in vitro human Immune response Testing of drug compounds, is a system of biological and analytical assays to study the interaction of a drug molecule with human tissues and assess drug induced adverse immune response that is generated through tissue damage. COMPIT is a preclinical system that can be applied to small molecules and large molecules. It integrates various immune and cellular assays available in our services currently and combines human cell lines, primary cells and 3D cultures to deliver an in vitro human cell-based immune system that recapitulates the in vivo human microenvironment.

This page is under moderation and further development. Please wait for information coming soon.